CONTOLI, Marco
 Distribuzione geografica
Continente #
NA - Nord America 14.101
AS - Asia 7.936
EU - Europa 4.617
SA - Sud America 1.293
AF - Africa 186
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 28.169
Nazione #
US - Stati Uniti d'America 13.804
SG - Singapore 3.224
CN - Cina 1.760
IT - Italia 1.180
BR - Brasile 1.005
VN - Vietnam 915
DE - Germania 791
HK - Hong Kong 677
UA - Ucraina 505
FI - Finlandia 471
GB - Regno Unito 392
TR - Turchia 345
FR - Francia 300
SE - Svezia 232
JP - Giappone 220
PL - Polonia 204
RU - Federazione Russa 197
ID - Indonesia 178
IN - India 163
MX - Messico 148
BD - Bangladesh 124
AR - Argentina 119
CA - Canada 112
NL - Olanda 93
ZA - Sudafrica 67
IQ - Iraq 55
PK - Pakistan 52
ES - Italia 47
CO - Colombia 36
EC - Ecuador 36
UZ - Uzbekistan 36
AT - Austria 32
BE - Belgio 32
LT - Lituania 32
PY - Paraguay 28
PH - Filippine 26
MA - Marocco 24
CZ - Repubblica Ceca 22
AU - Australia 21
VE - Venezuela 21
KR - Corea 19
MY - Malesia 19
TN - Tunisia 17
CL - Cile 16
KE - Kenya 16
PE - Perù 15
SA - Arabia Saudita 15
DZ - Algeria 14
AE - Emirati Arabi Uniti 13
EG - Egitto 13
JO - Giordania 12
UY - Uruguay 12
IE - Irlanda 11
AZ - Azerbaigian 9
AL - Albania 8
TW - Taiwan 8
CH - Svizzera 7
ET - Etiopia 6
GE - Georgia 6
HR - Croazia 6
HU - Ungheria 6
KH - Cambogia 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
RO - Romania 6
IL - Israele 5
IR - Iran 5
JM - Giamaica 5
KZ - Kazakistan 5
LB - Libano 5
LK - Sri Lanka 5
MK - Macedonia 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
CR - Costa Rica 4
EU - Europa 4
KG - Kirghizistan 4
NG - Nigeria 4
BG - Bulgaria 3
CY - Cipro 3
DO - Repubblica Dominicana 3
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
MD - Moldavia 3
MU - Mauritius 3
SI - Slovenia 3
SN - Senegal 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BY - Bielorussia 2
Totale 28.125
Città #
Singapore 1.999
Ashburn 1.766
Fairfield 1.248
Woodbridge 1.044
Houston 971
San Jose 935
Hong Kong 665
Santa Clara 638
Jacksonville 560
Beijing 547
Chandler 537
Ann Arbor 508
Seattle 496
Wilmington 493
Cambridge 428
Munich 378
Ho Chi Minh City 310
Helsinki 280
Los Angeles 261
New York 221
Hanoi 210
Tokyo 208
Dallas 206
Council Bluffs 205
Warsaw 189
Ferrara 188
Izmir 187
Nanjing 179
Princeton 169
Lauterbourg 164
Milan 162
Jakarta 134
San Diego 105
Chicago 100
São Paulo 100
Boardman 90
Shanghai 88
Mexico City 86
Orem 67
London 66
Addison 64
Rome 62
Turku 57
Dearborn 55
Frankfurt am Main 52
Nanchang 50
Da Nang 49
Shenyang 49
Tianjin 47
Atlanta 44
Bologna 44
Buffalo 44
Hefei 43
Toronto 41
The Dalles 40
Brooklyn 39
Chennai 39
Washington 37
Mountain View 35
Denver 33
Montreal 32
Moscow 32
Tashkent 32
Boston 31
Changsha 31
Rio de Janeiro 31
Hebei 30
Nuremberg 30
Brussels 29
Haiphong 29
Jiaxing 29
Amsterdam 28
Redwood City 28
San Francisco 28
Johannesburg 27
Falls Church 26
Guangzhou 26
Salt Lake City 26
Manchester 24
Stockholm 23
Dhaka 22
Jinan 22
Lappeenranta 22
Norwalk 22
Phoenix 22
Baghdad 21
Ankara 19
Bremen 19
Columbus 19
Falkenstein 18
Istanbul 18
Mumbai 18
Orange 18
Buenos Aires 17
New Delhi 17
Poplar 17
Dong Ket 16
Hải Dương 16
Kunming 16
Zhengzhou 16
Totale 19.059
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 445
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 429
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 354
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 337
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 306
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 304
Targeting Th2 cells in asthmatic airways 298
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 275
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 260
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 259
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 258
Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients 257
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 250
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 249
The contribution of small-Airway abnormalities in chronic obstructive pulmonary disease clinical manifestations: More than a functional issue 248
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 244
Anti-SARS-Cov-2 IgA response in tears of COVID-19 patients 240
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 234
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 230
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 226
Physiologic Evaluation of Ventilation Perfusion Mismatch and Respiratory Mechanics at Different Positive End-expiratory Pressure in Patients Undergoing Protective One-lung Ventilation 220
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 216
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 216
A serum proteome signature to predict mortality in severe COVID-19 patients 214
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 211
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 211
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 208
A simple method for home exercise training in patients with chronic obstructive pulmonary disease: One-year study 208
Is Peripheral Oxygen Saturation a Reliable Predictor of Upper Airways Air-Flow Limitation? 203
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 203
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 199
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 199
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 198
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 197
Cellule staminali e patologia polmonare dell’adulto 196
Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells 192
Models of infection and exacerbations in COPD. 189
Rhinovirus vaccination: the case against 189
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 187
Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells 184
Asthma management in a specialist setting: Results of an Italian Respiratory Society survey 181
Peak atrial longitudinal strain is predictive of atrial fibrillation in patients with chronic obstructive pulmonary disease and coronary artery disease 180
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 179
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 178
Right Ventricle Function in Patients with Acute Coronary Syndrome and Concomitant Undiagnosed Chronic Obstructive Pulmonary Disease 178
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 177
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 176
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 175
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses 174
Asthma: A Chronic Infectious Disease? 173
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease 173
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 172
From intensive care to rehabilitation: survey on the satisfaction with care received during prolonged hospitalization for COVID-19 at a northern Italian university hospital 171
Midazolam in flexible bronchoscopy premedication: effects on patient-related and procedure-related outcomes. 171
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 171
Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study 171
Satisfaction with chronic obstructive pulmonary disease treatment: results from a multicenter, observational study 167
Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients 165
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 163
IFN-alpha/IFN-lambda responses to respiratory viruses in paediatric asthma 163
A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: A proposal for COPD management 162
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 162
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 161
Disease awareness in patients with COPD: measurement and extent 160
Healthcare costs of the SATisfaction and adherence to COPD treatment (SAT) study follow-up 160
Interactions of airway pathogens and inflammatory processes 159
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure 158
When asthma diagnosis becomes a challenge 157
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 156
Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease 156
Pathophysiology of viral-induced exacerbations of COPD 155
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 155
Symptom variability and control in COPD: Advantages of dual bronchodilation therapy 155
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): Focus on virus induced exacerbations 155
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 154
ELEMENTI DI VALUTAZIONE E DIAGNOSTICA FUNZIONALE DELL’APPARATO RESPIRATORIO 154
Air Pollution Exposure Impairs Airway Epithelium IFN-β Expression in Pre-School Children 153
Bronchial epithelial cells from asthmatic children have a deficient innate immune response to rhinovirus infection 152
Clinical and Functional Characteristics of COPD Patients Across GOLD Classifications: Results of a Multicenter Observational Study 151
Interactions of airway pathogens and inflammatory processes 151
Molecular mechanisms of respiratory virus-induced asthma and COPD exacerbations and pneumonia 149
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 149
Small airway disease in asthma: pathophysiological and diagnostic considerations 149
Models of respiratory infections: Virus-induced asthma exacerbations and beyond 148
Left atrial pressure in patients with respiratory failure due to SARS-CoV-2 infection and supraventricular arrythmias 148
Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine 147
Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD 147
Deficient immune response to viral infections in children predicts later Asthma persistence 147
Withdrawal of inhaled corticosteroids in COPD: A meta-analysis 146
Do small airway abnormalities characterize asthma phenotypes? In search of proof. 144
Lymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease 144
Increased deposition of activated complement in peripheral lung vessels of smokers 144
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations 144
Diffuse panbronchiolitis as parathymic syndrome in a Caucasian man previously treated for thymoma 144
Increased sHLA-G is associated with improved COVID-19 outcome and reduced neutrophil adhesion 144
The Additional Value of Lower Respiratory Tract Sampling in the Diagnosis of COVID-19: A Real-Life Observational Study 143
Interleukin-4 Modulates Rhinovirus Replication and Antiviral Immune Response in Respiratory Epithelial Cells 143
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 142
Mechanisms of respiratory virus-induced asthma exacerbations 141
Rhinovirus-induced bronchial mucosal inflammatory response in asthma 141
Totale 19.231
Categoria #
all - tutte 131.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.168
Totale 136.154


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021763 0 0 0 0 0 0 0 0 0 305 266 192
2021/20221.529 74 125 108 140 56 80 85 98 65 116 160 422
2022/20231.438 185 62 69 145 205 192 107 117 174 26 104 52
2023/2024980 74 107 48 29 59 170 38 68 34 34 49 270
2024/20254.690 100 107 363 166 530 446 208 290 833 523 596 528
2025/202611.481 1.084 493 1.032 1.460 1.910 790 1.546 747 1.210 1.209 0 0
Totale 28.594